LANDEC CORPORATION (NASDAQ:LNDC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)     On January 18, 2017, Larry D. Hiebert, advised Landec Corporation (the “Company”) that he would be retiring as President of Lifecore Biomedical, Inc. (“Lifecore”) and Vice President of the Company effective on June 1, 2017, the week after the end of the Company’s fiscal year. Mr. James Hall, who is currently Vice President and General Manager of Lifecore and who has worked at Lifecore for over 18 years, will replace Mr. Hiebert as President of Lifecore.

About LANDEC CORPORATION (NASDAQ:LNDC)

Landec Corporation designs, develops, manufactures and sells a range of health and wellness products for food and biomaterials markets. The Company licenses technology applications to partners. The Company operates through three segments: Packaged Fresh Vegetables, Food Export and Biomaterials. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. The Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products primarily to Asia. The Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-hyaluronan (HA) products for medical use primarily in the ophthalmic, orthopedic and other markets.

LANDEC CORPORATION (NASDAQ:LNDC) Recent Trading Information

LANDEC CORPORATION (NASDAQ:LNDC) closed its last trading session down -0.15 at 12.50 with 35,547 shares trading hands.